Skip to Main Content

A large percentage of drug makers, universities, and hospitals continue to fail to publicly post clinical trials results, according to new data released by European officials, who took the opportunity to issue a reminder that the information is required in the interest of improving public health.

As of April, results were available for nearly one-third of completed clinical trials that were registered in the European Union clinical trials database, also known as EudraCT. Specifically, of almost 27,100 trials that were completed, results should have been posted for more than 18,400 of them, but results were available for only approximately 5,800 trials.


“This is an encouraging trend, though there is still significant progress to be made,” Anne Bucher, the director-general for health and food safety at the European Commission; Guido Rasi, who heads the European Medicines Agency; and Thomas Senderovitz, who chairs the Heads of Medicines Agencies, wrote in an open letter to clinical trial sponsors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!